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Abstract
S. aureus is a highly successful pathogen that is speculated to be the most common cause of human disease. The
progression of disease in S. aureus is subject to multi-factorial regulation, in response to the environments encountered
during growth. This adaptive nature is thought to be central to pathogenesis, and is the result of multiple regulatory
mechanisms employed in gene regulation. In this work we describe the existence of a novel S. aureus regulator, an as yet
uncharacterized ECF-sigma factor (sS), that appears to be an important component of the stress and pathogenic responses
of this organism. Using biochemical approaches we have shown that sS is able to associates with core-RNAP, and initiate
transcription from its own coding region. Using a mutant strain we determined that sS is important for S. aureus survival
during starvation, extended exposure to elevated growth temperatures, and Triton X-100 induced lysis. Coculture studies
reveal that a sS mutant is significantly outcompeted by its parental strain, which is only exacerbated during prolonged
growth (7 days), or in the presence of stressor compounds. Interestingly, transcriptional analysis determined that under
standard conditions, S. aureus SH1000 does not initiate expression of sigS. Assays performed hourly for 72h revealed
expression in typically background ranges. Analysis of a potential anti-sigma factor, encoded downstream of sigS, revealed it
to have no obvious role in the upregulation of sigS expression. Using a murine model of septic arthritis, sigS-mutant infected
animals lost significantly less weight, developed septic arthritis at significantly lower levels, and had increased survival rates.
Studies of mounted immune responses reveal that sigS-mutant infected animals had significantly lower levels of IL-6,
indicating only a weak immunological response. Finally, strains of S. aureus lacking sigS were far less able to undergo
systemic dissemination, as determined by bacterial loads in the kidneys of infected animals. These results establish that sS is
an important component in S. aureus fitness, and in its adaptation to stress. Additionally it appears to have a significant role
in its pathogenic nature, and likely represents a key component in the S. aureus regulatory network.
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Introduction
Staphylococcus aureus is a major human pathogen that is a leading
agent of both nosocomial and community acquired infections. It is
both a highly successful and dangerous pathogen that poses a
significant threat to public health due to the increased prevalence
of antibiotic resistant strains, such as methicillin-resistant S. aureus
(MRSA) [1–4]. The appearance in recent years of true
vancomycin-resistant MRSA [5–9] presents us with a frightening
prospect of a return to the days of pre-antibiotic medicine, where
the vast majority of staphylococcal bloodstream infections proved
fatal. One of the overwhelming reasons that S. aureus is such a
successful and diverse pathogen is the arsenal of virulence
determinants encoded within its genome, which include hemoly-
sins, toxins, adhesins and other exoproteins, such as proteases,
staphylokinase and protein A [10,11]. These damaging virulence
factors are subject to multi-level and multi-factorial regulation,
both temporally and spatially, in response to the environments
encountered during growth [11]. This responsive and adaptive
nature is thought to be central to the disease-causing ability of the
organism, and is largely the result of the multiple regulatory
mechanisms it employs in gene regulation.
The large and wide reaching regulatory network employed by S.
aureus encompasses a variety of common bacterial regulatory
mechanisms, including two-component regulators, DNA binding
proteins, regulatory RNAs, sigma factors and a quorum sensing
system. There are thought to be sixteen two-component systems in
S. aureus, including those that are responsible for the modulation of
autolysis (ArlRS, LytRS), virulence (AgrAC, SaeRS) cell wall
synthesis/drug resistance (GraRS, VraSR), and the sensing of
external iron (HssRS) and oxygen (SrrRS) [12–18]. In addition
there is a central, master regulator of virulence, the Agr system,
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which is encoded by a four-gene locus that regulates pathogenesis,
and the shift from localized to invasive phenotypes [19–21].
Further regulators exist, including the 12 members of the SarA
family of DNA binding proteins [22], several of which have been
shown to be important in virulence factor synthesis (SarA, Rot,
SarT) [23–25]. There are also three metal-dependent DNA
binding proteins encoded within the S. aureus genome, two of
which (Fur and PerR) are required for the survival of S. aureus in
animal models of infection [26].
S. aureus also has 3 known sigma factors: a housekeeping sigma
factor, sA, originally described by Deora and Misra [27], and two
alternative sigma factors, sB and sH [28,29]. Of these three, sB is
by far the most widely studied, the effects of which are apparent in a
variety of cellular processes, including oxidative stress resistance,
pigmentation, protein secretion, biofilm formation, drug resistance,
adaptation to stress and the progression of disease [30–32]. Indeed,
strains of S. aureus lacking a functional sB are pleiotropically altered
at the phenotypic level, and demonstrate reduced virulence in in vivo
models of animal infection [30,33]. sA, encoded by the plaC gene,
was first identified over a decade ago based on its homology with sA
from B. subtilis [27]. It is analogous to other primary sigma factors in
that it is essential for growth, and controls much of the day-to-day
house-keeping transcription. Documentation of a third sigma factor,
sH, in S. aureus recently appeared in a study by Morikawa et al. [28].
Here it was shown that S. aureus possesses a homologue of the genetic
competence sigma factor, sH, from B. subtilis.
While the primary sigma factor directs much of the transcrip-
tion during growth, most organisms possess alternative sigma
factors that direct the transcription of specific regulons during
unusual physiological conditions. ECF, or extra-cytoplasmic
function, sigma factors form a distinct and diverse subfamily
within this class of regulators that often share distant or divergent
identity with other known s factors. As a group, they are by far the
most numerate of the sigma factor families [34,35], with
Streptomyces coelicolor possessing more than 50 such elements within
its genome. Other organisms, including Mycobacterium tuberculosis,
Pseudomonas aeruginosa and Bacillus anthracis encode 10 or more such
factors [34]. They have been identified in a variety of Gram-
negative and Gram-positive organisms, and have been shown to
have wide-ranging and varied roles in cellular physiology. These
include the adaptation to: antimicrobial compounds, salt stress,
elevated or reduced growth temperatures, acidic pH, detergents,
oxidative stress, disulphide stress, iron starvation, osmotic stress,
carbon and nitrogen stress, high pressure and light [36–45]. More
importantly however, as the number of ECF-sigma factors
identified grows, attention is turning to their often considerable
roles in the virulence of pathogenic organisms [46].
Unusually, S. aureus seemingly achieves its versatile and adaptive
nature with only a limited selection of sigma factors. So far only
three have been documented, and only one of these (sB) has been
shown to have a role in cellular adaptation and virulence. In this
work we describe the characterization of a fourth S. aureus sigma
factor, an apparent ECF-sigma factor, which is seemingly involved
in cellular fitness and the adaptation to stress. Additionally it
appears to have a significant role in the pathogenic nature of S.
aureus, and likely represents an additional, key component in the
regulatory network of this organism.
Results
Identification of SACOL1827 as a putative ECF-sigma
factor
During work in our laboratory on the membrane proteases of S.
aureus, we generated a mutation in RseP. Multiple publications on
RseP proteases in E. coli, B. subtilis and Pseudomonas aeruginosa
demonstrate that they commonly serve to cleave the anti-sigma
factors of extra-cytoplasmic function (ECF)-sigma factors [47–53].
As it has previously been proposed by Helmann that the genome
of S. aureus likely contains an ECF-sigma factor [34], we undertook
an exploration of the S. aureus genome so as to determine whether
an as yet unidentified ECF sigma factor was present. Using the
protein sequence of the 7 known B. subtilis ECF-sigma factors, a
novel protein (SACOL1827) bearing homology to the ECF-sigma
factors sM and sYlaC was discovered in the S. aureus genome
(Table 1). BLAST analysis with this protein sequence revealed
homology with other ECF-sigma factors from a variety of
organisms (Table 1). The gene coding this protein is present in
the genome of all of the sequenced strains of S. aureus. Equally, it is
present in the four other sequenced Staphylococcal genomes: S.
epidermidis ATCC 12228 and RP62A, as well as S. haemolyticus and
S. saprophyticus. Our initial investigations of SACOL1827, using in
silico protein analysis, demonstrated the presence of both regions 2
and region 4 of s70. Further, in silico protein folding analysis (using
the 3D-JIGSAW, FUGUE and PHYRE databases) generated
strong homology scores for both of these regions (between 95–
100% certainty for region 2, and 90–95% certainty for region 4).
Overall our predictive protein folding and modeling analyses
returned a probability value of p =,0.001 for sS against the
founding-member of the ECF-sigma factors, sE of E. coli.
A common observance of ECF-family proteins is that the genes
encoding the sigma factors are contiguous to a coding region
specifying an anti-sigma factor. Analysis of the SACOL1827 locus
revealed a putatively transcriptionally-linked downstream gene
(SACOL1828) that is separated from SACOL1827 by 112 bp.
SACOL1828 is a conserved hypothetical protein with no
discernable homology to other proteins within the databases,
other than its direct homologues in staphylococci. In silico analysis
determined that these two genes are found clustered in this
arrangement in all of the sequenced S. aureus genomes (including
the RF122 bovine mastitis strain); in S. epidermidis ATCC 12228
and RP62A; and in S. haemolyticus and S. saprophyticus. Commonly
the anti-sigma factors of ECF-sigma factors possess membrane
associated domains, however analysis of SACOL1828 using a
Kyte-Doolittle hydrophobicity plot revealed no such region.
Interestingly, some ECF anti-sigma factors possess an
H(XXX)C(XX)C motif, as is the case in Streptomyces coelicolor and
Mycobacterium tuberculosis [54–56]. SACOL1828 bears a similar
sequence of H(LETN)C(VFH)C, which correlates well with that
found in other organisms.
Biochemical characterization of SACOL1827 reveals it to
be a sigma factor
Sigma factors bind to core RNAP in a reversible way in order to
induce transcription. To test the ability of S. aureus SACOL1827 to
bind to core-RNAP we generated recombinant protein using
standard E. coli overexpression techniques, and the 6HIS-tagging
vector pET24d (Novagen), as described previously [57]. Pulldown
assays were then performed using the purified protein and E. coli
core-RNAP (Epicentre). Recombinant SACOL1827 was coupled
to Ni-NTA agarose beads (via the HIS tag), followed by the
addition of core RNAP. Beads were then washed, resuspended in
sample buffer and loaded onto a SDS-PAGE gel. As a control, this
analysis was repeated in parallel omitting purified SACOL1827.
We determined that in the absence of SACOL1827, core-RNAP
was unable to bind the Ni-NTA beads, whilst in the presence of
SACOL1827 core-RNAP copurified upon elution (Fig. 1A).
Another common feature of ECF-sigma factors is that they have
a role in the autoregulation of their own expression. With this in
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mind we decided to test the ability of SACOL1827 to initiate
transcription from its own locus by transcriptional run off analysis.
Core-RNAP was preincubated with purified SACOL1827 protein
for 15 mins at 4uC, before the addition of an 1168 bp DNA-
fragment containing the sigS coding region and 945 bp of
upstream sequence. After further incubation (at 37uC for 15mins)
transcription was initiated by the addition of rNTPs, and allowed
to proceed for 30 mins. The mixture was then cleaned via two
acid-phenolchloroform extractions (to remove DNA contamina-
tion), and an isopropanol precipitation. The purified mRNA
transcript was then subject to a 1-step RT-PCR reaction with
primers internal to the SACOL1827 coding region (104 bp from
the initiation codon to 137 bp from the termination codon). This
experiment was repeated with controls, where either purified
SACOL1827 protein or core-RNAP was omitted from the
reaction mixture. The RT-PCR reactions were then resolved on
a 2% agarose gel (Fig. 1B), and revealed that only the
SACOL1827-core-RNAP complex lane yielded the expected
DNA fragment of 274 bp. The 2 control lanes demonstrated an
absence of bands, indicating that the acid-phenolchloroform
extractions effectively removed the template DNA. As the
SACOL1827-core-RNAP complex is capable of specifically
initiating transcription, we termed the SACOL1827 gene sigS,
and its resultant protein sS.
Analysis of a sigS mutant reveals a role for sS in the S.
aureus stress response
A common role of ECF-sigma factors is to protect bacterial cells
against external stress. In order to investigate if sigS has such a
purpose in S. aureus we created a SH1000 sigS::tet insertionally
inactivated mutant strain. Growth of the mutant was compared to
the wild-type and found to be indistinguishable in TSB media
under standard conditions (data not shown). However when long
term survival experiments were conducted (11 days, aerobic
growth, standard conditions) the sigS mutant showed a more
pronounced decrease in viability than the parental strain (Fig. 2A).
Table 1. Blast analysis for proteins homologous to SACOL1827 from Staphylococcus aureus.
Organism Assignment Identities Positives
No. of identical residues/total
no. of aligned residues
No. of similar residues/total
no. of aligned residues
B. subtilis sM ECF s factor 33/164 (20%) 73/164 (44%)
B. subtilis sYlaC ECF s factor 29/143 (20%) 69/143 (48%)
Idiomarina loihiensis ECF s factor 36/128 (28%) 69/128 (53%)
B. thetaiotaomicron ECF s factor 36/134 (26%) 72/134 (53%)
Pseudoalteromonas atlantica ECF s factor 35/121 (28%) 62/121 (51%)
B. cereus sM ECF s factor 31/108 (28%) 55/108 (50%)
V. parahaemolyticus ECF s factor 37/140 (26%) 70/140 (50%)
Oceanobacillus iheyensis ECF s factor 35/121 (28%) 59/121 (48%)
C. botulinum BotR/A s70 family 33/147 (22%) 78/147 (53%)
doi:10.1371/journal.pone.0003844.t001
Figure 1. Biochemical characterization of the SACOL1827 protein. (A) Pulldown Assay showing association of SACOL1827 with core-RNAP.
Lane order: L1, LMW Markers; L2, Monoclonal Anti-poly Histidine–Agarose antibody (with beads); L3, SACOL1827; L4, SACOL1827 (with beads); L5,
core-RNAP; L6, SACOL1827 + core-RNAP (with beads); L7, core-RNAP (with beads); L8, HMW Markers. (B) Transcription run-off assay. Lane order: L1,
DNA size markers; L2, transcription run-off conducted with core-RNAP + purified SACOL1827; L3, transcription run-off conducted with core-RNAP
only; L4, transcription run-off conducted with purified SACOL1827 only.
doi:10.1371/journal.pone.0003844.g001
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The sigS mutant strain lost viability at a consistently greater rate
than that of the parental strain, an effect that became more
pronounced as the experiment was prolonged. In order to assess
the long term implications of this, the mutant and parental strain
were subjected to starvation survival experiments over a period of
3 weeks (Fig. 2B). As with the 11 day experiment, the mutant
strain had a decreased viability during long term starvation when
compared to the parental strain.
ECF-sigma factors in a number of organisms have been shown
to be important in the response to elevated temperature stress
[38,44,58]. Therefore we tested the ability of the sigS mutant to
grow at elevated temperatures (40uC and 45uC), and to survive
heat shock (exponential cultures placed at 55uC for 15 mins before
being returned to growth at standard conditions). In each case the
sigS mutant strain responded to alterations in heat in a manner
akin to that of the parental strain (data not shown). However,
when we tested the viability of exponentially growing cultures
subjected to growth at 55uC, it was found that over a 2 hour
period the sigS mutant was more sensitive to killing by the elevated
temperature (Fig 3A). Following this, further death curves were
performed using the sigS mutant and its parental strain, in the
presence of 0.4 mg ml21 penicillin G, 50 mg ml21 lysostaphin and
0.05% Triton X-100. In the case of lysostaphin and penicillin G
no obvious difference was determined between the sigS mutant and
its parental strain. However, when Triton X-100 was used as a
lytic agent, the sigS mutant lysed at a quicker initial rate than that
of the parental strain (Fig. 3B). This early variations in lysis was not
borne out through the entire experimental time course, as the
parent and mutant strain reached equivalent levels of survival after
approximately 2 h.
Further to these experiments we set out to explore the role of
sigS in S. aureus physiology by subjecting the mutant strain to
growth analysis under a variety of different stress conditions. Disk
diffusions assays were conducted with SH1000 and the sigS mutant
in the presence of oxidative stress inducing compounds (30%
H202, 80% cumene hydroperoxide, 500mM diamide, 2M methyl
viologen, 1% menadione, 100mM plumbagin, 400 mg ml21
pyrogallol), nitric oxide stress inducing compounds (100mM
sodium nitroprusside), detergent stress (10% SDS, 10% Triton
X-100), acid (12M HCl) and alkali stress (6M NaOH), alcohol
stress (95% ethanol) and the antibiotics bacitracin (2 mg ml21),
vancomycin (2 mg ml21), penicillin G (5 mg ml21) and puromycin
(20 mg ml21). In each case no alteration in the zones of growth
inhibition were observed (data not shown). The mutant and
parental strain were tested further by growing them separately in
liquid media containing 1 M and 2.5 M NaCl, 20 mM Glucose,
and acidic and alkaline adjusted media (pH 5, with HCl; and
pH 9, with NaOH). Again no alterations in growth were detected
between the wild-type and mutant strain (data not shown).
Competitive growth analysis reveals the sS mutant has a
decreased fitness for survival
Competitive growth experiments were undertaken to assess the
viability of the SH1000 sS mutant when grown in coculture
Figure 2. Long term survival of the sigSmutant. The SH1000 sigS (&) mutant, along with its parental strain (X), were grown in TSB for 11 (A) or
21 (B) days. CFU/ml were determined at the specified intervals and are expressed as percentage survival.
doi:10.1371/journal.pone.0003844.g002
Figure 3. (A) Death curves of the sigS mutant and parental strain. (A), The effect of elevated temperature (55uC) on cellular viability.
Exponentially growing SH1000 (X) and the sigS mutant (&) were shifted from growth at 37uC to growth at 55uC, and viabilities were determine by
CFU/ml at the time intervals specified. The standard deviation of five replicate cultures is shown in the form of error bars. (B) Triton X-100 induced
lysis of the sigS mutant and its parental strain. SH1000 (X) and the sigS mutant (&) were lysed using 0.05% Triton X-100 and the CFU/ml determined
at the time intervals specified.
doi:10.1371/journal.pone.0003844.g003
The Role of SigS in S. aureus
PLoS ONE | www.plosone.org 4 December 2008 | Volume 3 | Issue 12 | e3844
experiments with its parental strain SH1000. These experiments
are facilitated by the fact that the sS mutant is marked with a
tetracycline resistance cassette; thus plating dilutions of the
coculture on both TSA (Tryptic Soy Agar) and TSA containing
tetracycline, allows derivation of exact colony counts for each
strain, and thus calculation of the competitive index (CI). What
was found was that SH1000 inoculated with the sS mutant in a
1:1 ratio resulted in a 1:0.28 ratio after 24 hours growth (Fig. 4).
The mutant was even further impaired in its competitive abilities
against the parental strain after 7 days of growth, resulting in a
growth ratio of 1:0.04. As ECF-sigma factors commonly serve to
protect the cell during times of stress we hypothesized that sigS
mutant would show additional decline in coculture experiments
with the parent when grown in the presence of sub-inhibitory
concentrations of stress-inducing compounds. Indeed, whilst little
variation from non-stressed conditions was observed after
24 hours growth, significant differences were observed after 7 days
growth. When the experiments were repeated using the oxidative
stress inducing chemicals hydrogen peroxide (1 mM) and diamide
(1.5 mM) 7 day ratios were found to be 1:0.02 and 1:0.01,
respectively. Additionally when the pH was altered in coculture
flasks using HCl (10 mM) or NaOH (10 mM) further declines
were seen, yielding 7 day ratios of 1:0.005 and 1:0.0006,
respectively. Similarly coculture experiments using the metal ion
chelator EDTA (0.1 mM) produced 7 day ratios of 1:0.003.
Finally, and most dramatically, experiments using penicillin G
(0.01 mg ml21) and ethanol (5%) yielded no detectable sigS mutant
colonies after 7 days of growth with the parental strain.
Transcription profiling analysis of sigS expression
In order to determine the timing and levels of sigS expression in
S. aureus we created a lacZ reporter-fusion strain of SH1000. We
cloned a 1405 bp fragment into the suicide vector pAZ106, which
bears a promoterless lacZ cassette. This 1405 bp fragment runs
from 945 basepairs upstream to 354 basepairs downstream of the
sigS initiation codon. The possibility of additional promoter
elements being present in this fragment was excluded by analysis
of the sigS locus, revealing that SACOL1826 is located 199 bp
from the sigS initiation codon, and is transcribed in a divergent
orientation. This plasmid was first introduced into RN4220 before
being transferred to SH1000. Analysis of this strain on TSA
containing X-Gal revealed no blue coloration, even after
incubation of up to 1 week. We then grew the SH1000 sigS-lacZ
strain in liquid media for 3 days, removing aliquots at 1 hour
intervals in order to assay for specific sigS expression. We found
that even after 3 full days of growth, we could determine no
expression of lacZ from the sigS reporter strain (Fig 5; maximum
miller units were 19 at 52 h). The construct and mutant were
Figure 4. Competitive growth analysis of the sigSmutant and its parental strain. SH1000 and its sigS mutant derivative were cocultured in
TSB or TSB containing subinhibitory concentrations of: hydrogen peroxide (1 mM), diamide (1.5 mM), HCl (10 mM), NaOH (10 mM), EDTA (0.1 mM),
penicillin G (0.01 mg ml21) or ethanol (5%). The competitive index (CI) was determined for each strain after the respective growth periods and
represents the relative proportion of the two strains after inoculation at a 1:1 ratio. Data is representative of at least 3 independent cultures.
doi:10.1371/journal.pone.0003844.g004
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independently regenerated 2 additional times to ensure that no
unwanted genetic rearrangements had occurred with the plasmid,
or plasmid bearing strains; yet in each case no sigS expression, as
determined by b-Galactosidase activity, was detectable.
Studies of ECF-sigma factors in other organisms have
demonstrated the induction of ECF-sigma factor expression in
response to stress inducing compounds. Specifically, in one such
study by Cao et al [59], an elegant disc-diffusion reporter-gene
fusion method was employed to define conditions conducive to the
expression of sW in B. subtilis. Thus we employed a similar
technique using our sigS-lacZ fusion strain. TSA plates were
overlayed with TSB top agar (0.7% w/v) seeded with exponen-
tially growing SH1000 sigS-lacZ cells, and containing 40 mg ml21
X-GAL. Sterile filter discs were overlayed onto these plates (3 per
plate), before being inoculated with 10 ml of the following stress
inducing chemicals: 30% H202, 80% cumene hydroperoxide,
500mM diamide, 2M methyl viologen, 1% menadione, 100mM
plumbagin, 400 mg ml21 pyrogallol, 100mM sodium nitroprus-
side, 10% SDS, 10% Triton X-100, 12M HCl, 6M NaOH, 95%
ethanol, 2 mg ml21 bacitracin, 2 mg ml21 vancomycin, 5 mg
ml21 penicillin G and 20 mg ml21 puromycin. Plates were
incubated for 24 h at 37uC and screened for conditions conducive
to sS expression as determined by a blue halo around the edge of
the filter discs. Upon analysis we found that none of the chemicals
tested resulted in the induction of sS expression, as determined by
a lack of blue coloration on any of the test plates (data not shown).
Investigating the effect of SACOL1828 on sigS expression
As referred to above, ECF-sigma factors are often encoded
upstream of an ORF that specifies an anti-sigma factor. Whilst
SACOL1828 would be an unusual anti-sigma factor, as it lacks
any obviously membrane associated domains, we decided to assess
its role on sigS expression. As sS seems to have a role in
autoinducing its own transcription, it follows that if SACOL1828
were to inhibit the activity of the sS protein, then a SACOL1828
mutant would have higher sigS expression, as a result of an
increase in free sS protein. Thus we generated a SACOL1828::tet
mutant in SH1000, before transducing it with the sigS-lacZ
reporter-gene fusion. The presence of both mutation and
reporter-fusion were confirmed by PCR analysis, and the strain
was assayed for b-Galactosidase activity. Much like that seen with
the SH1000 sigS-lacZ fusion alone, we found that the inactivation
of SACOL1828 had no effect on sigS expression. Indeed no b-
Galactosidase activity was detectable in this strain even after
1 week of growth on TSA containing X-GAL. Because of the close
proximity of the integration sites for the sigS-lacZ and SACOL1828
mutation we regenerated this strain via an alternative manner.
Electrocompetent RN4220 SACOL1828::tet cells were prepared,
and used as recipients for electroporation with the sigS-lacZ
construct. Clones were analyzed for the presence of both the
mutation and reporter-fusion by PCR analysis, before 2
representative clones were used to generate phage lysate using
w11. These lysates was then used to transduce SH1000, with
transductants selected for on the basis of the resistances of either
the mutation (tetracycline) or the reporter-fusion (erythromycin).
Clones were screened by PCR to confirm the efficient con-
stransduction of each marker. Again as with the sigS-lacZ reporter-
fusion strain, the regeneration of this strain did not result in
detectable b-Galactosidase activity.
sS is required for the full virulence of Staphylococcus
aureus
As the number of ECF-sigma factors identified grows, attention
is turning to their often considerable roles in bacterial virulence
[46]. Therefore we studied the impact of sS on the virulence of S.
aureus infection in a murine model of septic arthritis. Mice were
intravenously inoculated with either the parental strain (SH1000)
or its sigS mutant derivative. In initial experiments using higher
doses of bacteria, ranging from 4.56106 to 86106 bacteria per
mouse, infection with the sigS mutant gave rise to significantly less
mortality when compared to animals infected with SH1000
(Fig. 6A). Data from 3 pooled experiments showed that only 3 out
of 30 mice infected with the sigS mutant died during the 14 day
experimental period, compared with 10 out of 30 mice infected
with SH1000 (p,0.05). In addition, mice infected with the sigS
mutant lost significantly less weight than mice infected with
SH1000. At day 5 post-inoculation, mice infected with the sigS
mutant had lost on average only 4.4% (213.3% to +2.2%, IQR)
of their body weight, whereas SH1000 infected mice had a median
weight loss of 10.4% (220.2% to 25%, IQR) (p,0.05, Fig. 6B).
At later time points the weight changes in surviving animals were
similar in the two groups, probably due to the markedly higher
mortality of mice infected with SH1000. The development of
clinical arthritis was significantly less frequent in mice infected with
Figure 5. Expression analysis of sigS using a lacZ reporter-fusion strain. An SH1000 sigS-lacZ strain was grown for 72 hours, with samples
withdrawn every hour to quantify the relative amount of sigS expression (N). The OD600 of the strain was also measured at each time point, and is
shown (#).
doi:10.1371/journal.pone.0003844.g005
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the sigS mutant, than in mice given the same dose of SH1000
(Fig. 6C). At 7 days post-inoculation with the sigS mutant only 2
out of 17 mice (12%) had clinically overt arthritis, as compared to
10 out of 17 mice (59%) infected with SH1000 (p,0.05). In
addition, the severity of clinical arthritis at this time point was
significantly reduced in the sigS mutant-infected mice, as
compared to SH1000-infected mice (p,0.05, fig. 6D).
Fourteen days after inoculation all limbs from the mice
inoculated with 36106 to 46106 bacteria per mouse were
subjected to histopathological evaluation. As shown in figure 7A,
infection with the sigS mutant induced much less erosion of bone
and cartilage as compared to infection with the parental strain
(p,0.05). In addition, infection with the sigS mutant also induced
somewhat milder joint inflammation than SH1000 (Fig 7A),
although these results were not found to be statistically significant.
The systemic immune responses of mice infected with the sigS
mutant and SH1000 were also compared by analyzing the levels of
the proinflammatory cytokine interleukin (IL)-6 in serum 14 days
post-inoculation. Mice infected with 36106 bacteria of the sigS
mutant had a median serum IL-6 concentration of 147 pg/ml
(IQR 130–202 pg/ml; n= 10), which was markedly lower than the
IL-6 concentration found in mice infected with SH1000, which
had a median of 358 pg/ml (IQR 219–729 pg/ml; n= 10)
(p,0.001, Fig 7B). Finally we investigated the ability of the strains
to persist in host tissues, by determining the CFU/ml in kidney
tissue homogenates. For this purpose, samples were taken from the
kidneys 14 days after inoculation with 36106–46106 staphylococ-
ci per mouse. The sigS mutant clearly showed a reduced capacity
to colonize host tissues, as it could not be detected in the kidneys of
6 out of 17 mice (35.3%). In contrast, growth of SH1000 was seen
in the majority of infected animals, with only 2 out of 17 mice
having negative kidney cultures (11.8%). The median number of
staphylococci in the kidneys was 56104 (IQR 0–3.46107) bacteria
after inoculation with the sigS mutant, as compared to 3.26107
(IQR 2.56105–1.36108) after inoculation with SH1000. Similar
results were obtained after inoculation with higher doses of
bacteria (data not shown).
Discussion
S. aureus is a complex and versatile pathogen, which employs
many different strategies in order to bring about its pathogenic
response. It possess a diverse and wide-reaching network of
regulatory elements that serve to fine-tune the coordinated
expression of virulence determinants [13,15,20,23,24], so as to
specifically bring about infection in a targeted manner. Addition-
ally, there are a number of regulatory elements that contribute to
the S. aureus virulence process, by controlling cellular physiology,
and the adaptation to external conditions. The presumably
facilitate both adaptation and proliferation in the harsh environ-
ment of the host [17,18,26,31]. Such loci, whilst not always
directly controlling virulence determinant production, are no less
important to the virulence process, as they facilitate the rapid
physiological switching that is a hallmark of S. aureus. This kind of
Figure 6. sS is required for the full virulence of S. aureus in a murine model of septic arthritis. (A), The cumulative mortality of mice
(assessed by a log rank test, p,0.05). N = 30 per group. (B), Changes of body weight in the same mice as in A (*p,0.05 as compared using a Mann-
Whitney U test.). (C), Frequency of clinical arthritis in mice inoculated with either wild-type S. aureus (SH1000) or its isogenic sigS mutant. The data
from 2 separate experiments were pooled, n = 25 per group at day 3, n = 18 per group at days 5–10, and n= 10 per group at day 14. Statistical
comparisons were performed using a chi-square test with Yates correction (*p,0.05). (D), Severity of clinical arthritis in the same mice as in C. Data is
presented as medians (horizontal lines); inter-quartile ranges (bars) and ranges (error bars). An arthritic index was calculated by scoring all four limbs
of each animal. Statistical comparisons were performed using a Mann-Whitney U test (*p,0.05).
doi:10.1371/journal.pone.0003844.g006
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responsiveness is commonly induced in other organisms by sigma
factors, as they present a rapid and direct way of modulating
stimulons in response to change. Rather unusually, S. aureus
seemingly achieves its versatile and adaptive nature with only a
limited selection of sigma factors. So far only three have been
documented [27,28,29], and only one of these (sB) has been
shown to have a role in cellular adaptation and virulence
[30,31,33]. The work presented in this current study demonstrates
that an additional, and as yet uncharacterized, 4th sigma factor
(sS) exists in S. aureus. sS appears to be a member of the ECF-
family of sigma factors, and likely represents an important
component of the stress and pathogenic responses of this organism.
Using biochemical approaches we have shown that sS is able to
associates with core-RNAP, and initiate transcription from its own
coding region. The autoregulation of ECF-sigma factor expression
is a common hallmark of this family of regulators, and has been
observed amongst a great many of their number [34]. Addition-
ally, using a sigS mutant of S. aureus, we have shown that sS
contributes to the protection against external stress, and plays a
role in cellular fitness and survival. This is not unexpected, as the
majority of ECF-sigma factors studied have been shown to
function in the adaptation to stressful conditions [36–45]. In this
study we present that sS is important for S. aureus cellular survival
when faced with prolonged starvation, and extended exposure to
elevated growth temperatures. Additionally a sigS mutant is
seemingly less able to survive, at least initially, the attack on cell
wall stability posed by Triton X-100. The observation of these
phenotypes for sS is not out of keeping with other ECF-sigma
factors, as a number are known to contribute to either heat shock
responses and/or modulate cell wall stability [34].
On the other hand, using disc diffusion analysis, we were unable
to find any increased sensitivity of the sigS mutant to a variety of
chemical stresses, including those generating oxidative stress
(H202, cumene hydroperoxide, diamide, methyl viologen, mena-
dione, plumbagin, pyrogallol), nitric oxide stress (sodium nitro-
prusside), detergent stress (SDS, Triton X-100), acid and alkali
stress (HCl, NaOH), alcohol stress (ethanol) and antibiotic stress
(vancomycin, penicillin G, puromycin). Whilst this may appear
unusual, given that a number of ECF-sigma factors in other
organisms respond to these conditions, it is not entirely
inexplicable. ECF-sigma factors are selectively induced in response
to the specific stress that they are intended to combat. Thus it is
likely the case that in S. aureus, sS is not the primary arbiter of
adaptation to the stresses listed above. This is particularly
pertinent to oxidative and antibiotic stress, as S. aureus has a
variety of mechanisms by which to circumnavigate and survive
these threats [60–69]. Therefore it is probably that the efforts
exerted in the present study have yet to hit upon the specific
condition to which sS is required to respond. Indeed it possible,
given the data generated by our animal studies, that the specific
stress(es) sS responds to are not ones that can be simulated in vitro,
but are uniquely associated with the in vivo lifestyle of S. aureus.
With that said, it is apparent that sigS does present some benefit
to the cell during in vitro growth. In our coculture studies, where
the parent and mutant strain were grown together under a variety
of conditions, it was clear that sS was a significant aid to the
survival and fitness of S. aureus. When the SH1000 sigS mutant was
forced to compete with its parental strain, it displayed significantly
reduced abilities for growth and survival. This phenotype was only
exacerbated during prolonged growth periods (7 days), or in the
presence of external stressor compounds. This would tend to
suggest that sigS presents a selective advantage to S. aureus cells
both during standard growth conditions, as well as during times of
starvation and/or stress. Therefore it would seem logical that sS is
a valuable component for maintaining cellular harmony and
stability, and as such likely represents an important mechanism by
which S. aureus protects itself against the harsh environments
encountered during growth.
Our transcription profiling studies of sigS turned up some
interesting information regarding its expression. It appears that
during growth under standard conditions, S. aureus SH1000 cells
do not initiate expression from the sigS locus. Our studies, which
were sampled every hour for 3 days, consistently revealed
expression in the typically background range of 0–1 Miller units.
Only in 2 instances during growth did we detect anything higher
than these values (32–36 h, and 48–52 h), and even then maximal
expression was only 19 Miller units. We have generated a number
of lacZ reporter-fusion strains in a variety of S. aureus backgrounds
Figure 7. Analysis of the requirement for sS in S. aureus infection as measured via histopathological evaluation and mounted
immune response analysis. (A), Histopathological evaluation of all limbs from mice 14 days post infection. The levels of synovitis and erosion
(*p,0.05) were measured and mean scores are represented by vertical bars. (B), Serum IL-6 concentrations were determined for infected mice. All
samples were run in triplicate. ***p,0.001.
doi:10.1371/journal.pone.0003844.g007
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[30,70–72] (unpublished data), and have never seen a strain that
displays such limited expression under specific analysis. Even upon
the analysis of apparently very lowly expressed genes (e.g. SH1000
ssp-lacZ fusion), which display little to no blueness on TSA X-gal
plates, we routinely observe expression units in the hundreds [30].
With this in mind, and given the length of our transcription
experiment, it is likely that even these 2 windows of minor
expression may be the result of something other than actual
induction of the sigS operon (e.g. cellular lysis). Therefore, as
asserted above, this would tend to suggest that sigS is not expressed
in SH1000 during growth under standard conditions.
This is certainly an unusual observation, but as ECF-sigma
factors are commonly inducibley expressed in response to stress
conditions, it perhaps not surprising. Indeed, analysis of the ECF-
sigma factors of B. subtilis provides similar examples of transcrip-
tional regulation. For example it has been reported that
transcription of the ECF-sigma factor sZ from B. subtilis is
undetectable during growth in rich and minimal media [73].
Further, specific analysis of B. subtilis ECF-sigma factor expression,
conducted by Asai et al [74], revealed that the expression of sV,
sY and sYlaC, in addition to sZ, were all equally low, and barely
detectable during growth under standard conditions. In a study
aimed at defining conditions conducive to sW expression in B.
subtilis, by Cao et al [59], an elegant disc-diffusion reporter-gene
fusion method was employed. Cells bearing a sigW-lacZ fusion
were grown on LB agar containing X-GAL, and overlayed with
filter discs containing a variety of antibiotics. Using this approach,
chemicals conducive to sW expression yielded a halo of blue
around the edge of the filter disc. We employed just such an
approach with our SH1000 sigS-lacZ fusion, using the chemicals
previously tested in sensitivity assays with the SH1000 sigS mutant.
Perhaps unsurprisingly, we found none of the chemicals tested
resulted in an increase in sS expression. This would tend to add
further weight to our assertion that in the present study have yet to
hit upon the specific condition to which sS is induced in S. aureus.
Further transcriptional analysis focused on the role of
SACOL1828 on sS expression. As referred to above, ECF-sigma
factors are often encoded upstream of an ORF that specifies an
anti-sigma factor. As sS seems to have a role in autoinducing its
own transcription, it follows that if SACOL1828 were to inhibit
the activity of the sS protein, then a mutation in SACOL1828
would have higher sigS expression as a result of more free and
active sS protein. Indeed similar approaches have been used to
analyze the putative anti-sigma factors of B. subtilis ECF-sigma
factors, including sYlaC and sX [75,76]. Our analysis found that
inactivating SACOL1828 did not result in an increase in sigS
expression, as would have been predicted if SACOL1828 were to
function as an anti-sigma factor. We suggest, however that this
observation may be explained by the apparent lack of sigS
expression in SH1000. If, as we find, there is little to no sigS
expression in SH1000 during growth under standard conditions,
then it follows that there is little to no sS protein present in the
cell. Therefore the inactivation of a sS anti-sigma factor would not
bring about the predicted snowballing of sigS expression, resulting
from free sS protein being able to auto-stimulate its own
transcription. Thus it appears that further investigation is required
before we can specifically determine whether SACOL1828 plays
any role in the regulation of sS activity.
The most striking, and indeed important, role we have defined
for sS is its role in the virulence of S. aureus. Using our murine
model of septic arthritis infection we have demonstrated that in
each of the tests applied, to determine the extent and severity of
disease, S. aureus cells lacking a functional sigS gene were
significantly impaired in their ability to establish and maintain
infection. Mice infected with S. aureus in this model lose weight,
undergo extreme destruction of joints, bone and cartilage, and
ultimately die. However those mice infected with the sigS mutant
lost significantly less weight, developed septic arthritis at
considerably lower levels, and most tellingly, had considerably
increased survival rates. In addition, our studies of mounted
immune responses by infected mice reveal that those animals
infected with the sigS mutant had significantly lower levels of IL-6,
indicating only a very weak immune response to the invading
pathogens. Finally, a major hallmark of septic arthritis is systemic
dissemination, moving from the site of infection into the kidneys.
Our analysis reveals that mice infected with the parental strain
possessed large numbers of S. aureus cells in the kidneys of infected
mice. However when the same analysis was conducted with the
sigS mutant it was apparent that strains of S. aureus lacking a
functional sigS gene were far less able to undergo systemic
dissemination. Collectively, the virulence data that we present
speaks very strongly to the importance of sS in the ability of S.
aureus to cause disease, a fundamental cornerstone of its innate
behavior.
From our investigations presented here we have demonstrated
that sS is important for the S. aureus stress response, aiding in the
protection against unfavorable conditions. In addition we have
shown that it is vital for the infectious nature of S. aureus, as a sigS
mutant is attenuated in virulence in a murine model of septic
arthritis infection. However the specific and mechanistic role of sS
in S. aureus biology remains unknown. It is unlikely; thought not
impossible, that sS wields its role via direct regulation of virulence
determinant expression. A more probable scenario is that sS, as
with other ECF-sigma factors, is responsible for sensing and
responding to discrete external cue(s); and changing S. aureus gene
expression profiles so as to protect the cell. It is the current and
future purpose of our laboratory to explore and develop an
understanding of the role of sS, which will doubtlessly further our
knowledge of this important human pathogen and its disease
causing abilities.
Materials and Methods
Bacterial strains, plasmids and growth conditions
The S. aureus and E. coli strains, along with the plasmids used in
this study are listed in Table 2. E. coli was grown in Luria-Bertani
(LB) medium at 37uC. S. aureus was grown in 100 ml TSB (1:2.5
flask/volume ratio) at 37uC with shaking at 250 rpm, unless
otherwise indicated. For growth analysis experiments, overnight
cultures were inoculated into fresh media to an OD600 of 1.0 and
allowed to grow for 3 hours. These cultures were then in turn used
to inoculate fresh TSB to an OD600 of 0.01, and these were used as
test cultures. CFU/ml counts were determined by the serial
dilution of test-cultures onto TSA, followed by enumeration after
overnight growth. All CFU/ml values represent the mean from
three independent experiments. When required antibiotics were
added at the following concentrations: ampicillin 100 mg ml21 and
tetracycline 12.5 mg ml21 (E. coli); tetracycline 5 mg ml21,
erythromycin 5 mg ml21and lincomycin 25 mg ml21 (S. aureus).
Where appropriate, X-GAL was added to media at a concentra-
tion of 40 mg ml21.
Overexpression and Purification of sS
The 470bp sigS coding region was PCR generated using primer
pair OL-389/OL-390 and cloned into the E. coli overexpression
vector pET24d (Novagen) to create pLES200. The plasmid was
subjected to DNA sequence analysis (UGA core facility) to ensure
that the coding region was generated without mistake. This
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plasmid was purified from E. coli DH5a and transferred to the E.
coli expression host Tuner (Novagen). Cells were grown at 37uC (in
LB supplemented with 34 mg/l chloramphenicol and 30 mg/l
kanamycin) before the induction of protein expression with
100 mM IPTG at an OD600 of 0.5. The culture temperature
was then reduced to 30uC and growth was permitted for a further
4–5 h with vigorous agitation. Cells were harvested by centrifu-
gation (10 min, 4,500 g), resuspended (Buffer A: 50 mM Tris-HCl
pH 8.0, 100 mM NaCl, 50 mM imidazole) and disrupted by
sonication. Soluble protein fractions, collected by centrifugation
(30 min, 14,000g, 4uC), were applied to a Chelating Sepharose
(Amersham) Ni2+ affinity column (1.5cm61.6cm). To ensure
saturated binding of the recombinant sS to the matrix, samples
were circulated through the column for 2.5 h using the Akta
Explorer system (Amersham), and then washed extensively with
Buffer A until the OD280 of the eluate dropped to a baseline
reading. Recombinant sS was eluted from the column in a
stepwise manner with buffer A containing imidazole at 140, 320
and 500 mM concentrations. Fractions eluted at 320 mM were
pooled and lyophilized in order to concentrate the purified
recombinant protein. This was then resuspended in water,
desalted (HiTrap desalting column, Amersham) by buffer
exchange (20 mM Tris-HCl pH 8.0, 20 mM NaCl) and re-
lyophilized. Protein purity was assayed by SDS-PAGE, yielding a
Table 2. Strains, plasmids and primers used in this study. Where applicable restriction sites are underlined.
Strain, Plasmid or Primer Genotype or Description Reference/Source
E. coli
DH5a w80 D( (lacZ)M15 D( (argF-lac)U169 endA1 recA1 hsdR17 (rK
2mK
+) deoR thi-1
supE44 gyrA96 relA1
78
Tuner F2 ompT hsdSB (rB
2 mB
2) gal dcm lacY1(DE3) pLysS (CamR) Novagen
S. aureus
RN4220 Restriction deficient transformation recipient Lab Stocks
SH1000 Functional rsbU derivative of 8325-4 rsbU+ 30
LES55 SH1000 sigS::tet sigS2 This Study
LES56 SH1000 SACOL1828::tet SACOL18282 This Study
LES57 SH1000 pAZ106::sigS-lacZ sigS+ This Study
LES58 RN4220 SACOL1828::tet SACOL18282 This Study
LES59 RN4220 SACOL1828::tet pAZ106::sigS-lacZ sigS+ SACOL18282 This Study
Plasmids
pAZ106 Promoterless lacZ erm insertion vector 77
pET24d 6His-tag overexpression vector Novagen
pLES200 pET24d containing a 470bp sigS fragment This Study
pLES201 pAZ106 containing a 2.3kb sigS fragment This Study
pLES202 pAZ106 containing a 2.2kb SACOL1828 fragment This Study
pLES203 pLES201 containing a tetracycline cassette within sigS This Study
pLES204 pLES202 containing a tetracycline cassette within SACOL1828 This Study
pLES205 pAZ106 containing a 1.4kb sigS fragment This Study
Primers
OL-281 ACTGGATCCCAGTTGCAGATGCATCTCTCC
OL-282 AGCTAGGCATGCCAAGTCTATCTGGCGTAC
OL-285 ACTGGATCCGACCATCACGATACATCA
OL-286 CTTCACTGACAACTATGCCG
OL-287 GCGATTACATTCTAGAAGTTCC
OL-288 GGAACTTCTAGAATGTAATCGC
OL-293 ATGGAATTCGTTTGAGCCATAGTCTTTCTC
OL-297 ATGGAATTCCTAATTAAAATTATGTTGGCATTTA
OL-387 GATGAGTATTATCAACTACTCTTG
OL-389 ATGACCATGGTGAAATTTAATGACGTATAC
OL-390 ATGACTCGAGATTAAAATTATGTTGGATTTTACGC
OL-429 TATCAACTACTCTAGATAAAAATGTGGC
OL-430 GCCACATTTTTATCTAGAGTAGTTGATA
OL-522 ATGTCTAGAGAGTAATGCTAACATAGC
OL-523 ATGTCTAGACCCAAAGTTGATCCCTTAACG
doi:10.1371/journal.pone.0003844.t002
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single band with a molecular mass of 19 kDa. The presence of the
6His-Tag in recombinant sS was confirmed by Western Blot with
anti-HisTag antibodies (Roche).
sS-Core RNAP Association Experiments
200 ml of anti-His-tag antibodies conjugated to agarose beads
(Sigma) were washed thoroughly (20 mM Tris-HCl pH 8.0,
10 mM NaCl) and incubated with 250 ml of 0.2 mg/ml
recombinant sS at room temperature for 3 h. The resin was
washed thoroughly with 20 mM Tris-HCl pH 8.0, 10 mM NaCl
and TBS-Tween, before adding 20 ml of core-RNAP at 1U ml21
(Epicentre). Samples were then incubated for 2(h at room
temperature followed by extensive washing. After adding SDS-
PAGE sample buffer, samples were boiled and centrifuged
(10(min, 16 000(g), and the supernatant subjected to SDS-PAGE.
Transcription Run-Off Experiments
0.25 mg of core-RNAP (Epicentre) was preincubated with 1 mg of
sS in transcription buffer [30mM Tris-HCl (pH 8.0), 10mM
MgCl2, 100mM KCl, 1mM DTT], at 4uC for 15mins. After this
time, 1 mg of a 1168 bp DNA-fragment (PCR generated using
primer OL-281/OL-297), containing the sigS coding region and
945 bp of upstream sequence, was added to the sS-core-RNAP
complex, and further incubated at 37uC for 15mins. Transcription
was initiated by the addition of 2.5 mM rNTPs, and transcription
was allowed to proceed for 30 mins at 37uC. After this time the
mixture was cleaned via 2 acid-phenolchloroform extractions (to
remove DNA contamination), followed by isopropanol precipita-
tion. The purified mRNA transcript was then subjected to a 1-step
RT-PCR reaction using primer pair OL-387/OL-293 (104 bp from
the initiation codon to 137bp from the termination codon, with a
target fragment size of 274bp) and the Superscript III enzyme
(Invitrogen). This experiment was repeated, omitting either purified
sS or core-RNAP as controls. RT-PCR reactions were resolved on
a 2% agarose gel and visualized using a BioDocIt Device (UVP).
Construction of the sigS and SACOL1828 mutant strains
A plasmid for the mutagenesis of sigS was constructed by PCR
amplification. Two approximately 1kb fragments were PCR
generated surrounding the sigS coding region (1 located upstream,
primer pairs OL-281/OL-430; and 1 located downstream, primer
pairs OL-282/OL-429). Primers OL-429 and OL-430 are
identical, but divergent to each other, and each contain base pair
mismatching, converting the wild type sequence of TCAAGC
(,100bp from the sigS Met) to TCTAGA, an XbaI restriction
recognition site. These fragments were purified and used together
as the template for a further round of PCR with primer pair OL-
281/OL-282. The resultant 2.3 kb DNA fragment was digested
with BamHI and SphI, and cloned into the suicide vector pAZ106
[77] to generate pLES201, using standard cloning techniques [78].
A plasmid for the mutagenesis of SACOL1828 was constructed in
a similar manner with the following exceptions. The two approxi-
mately 1kb fragments were generated using primer pairs OL-285/
OL-288, and OL-286/OL-287. Primers OL-287 and OL-288 are
identical, but divergent to each other, and contain mismatching that
converts the wild type sequence of TCTTAA (,100bp from the
SACOL1828 Met) to a TCTAGA XbaI site. These fragments were
used as the template for further PCR using primer pair OL-285/OL-
286. This 2.2 kb DNA fragment was digested with BamHI and SphI
and cloned into pAZ106 to generate pLES202 .
The novel XbaI sites in pLES201 and pLES202 were then used
as a target sites for the insertion of a tetracycline resistance
cassette, generated from pDG1515 [79] using primer pair OL-
522/OL-523. The XbaI digested cassette was cloned into
pLES201 and pLES202, yielding pLES203 (sigS) and pLES204
(SACOL1828). These were then used to transform electrocompe-
tent S. aureus RN4220, according to the method of Schenk and
Ladagga [80], with clones selected for on the basis of tetracycline
and erythromycin resistance. Integrants were confirmed by PCR
analysis (data not shown) and used as donors for the transduction
of S. aureus strain SH1000 using phage w11. Transductants were
selected for their resistance to tetracycline (indicating the presence
of the cassette) and sensitivity to erythromycin (indicating loss of
the plasmid and associated functional copy of sigS or SA-
COL1828), before being confirmed by PCR analysis. This created
strains LES55 (sigS) and LES56 (SACOL1828).
Construction of a sigS-lacZ reporter-fusion strain
The putative promoter region of sigS was amplified as a 1.4 kb
PCR fragment using primer pair OL-281/OL-293 (Table 2). The
purified DNA fragment was digested with BamH1 and EcoRI and
cloned into similarly digested pAZ106. S. aureus RN4220 was
transformed with the resulting plasmid, pLES205, and integrants
were confirmed by PCR analysis. A representative clone was then
used to transduce S. aureus SH1000 using w11, with clones again
confirmed by PCR analysis. This created strain LES57 (sigS-lacZ).
b-Galactosidase assays
Levels of b-Galactosidase activity were measured as described
previously [71]. Fluorescence was measured using a Bio-Tek
Synergy II plate reader, with a 0.1 sec count time, and calibrated
with standard concentrations of MU (4-methyl umbelliferone).
One unit of b-Galactosidase activity was defined as the amount of
enzyme that catalyzed the production of 1 pmol MU min21
OD600 unit
21. Assays were performed on duplicate samples and
the values averaged. The results presented here were representa-
tive of three independent experiments that showed less than 10%
variability.
Disc-Diffusion Assays
Disk diffusion sensitivity assays were performed as follows: 5 ml
of TSB top agar (0.7%, wt/vol) was seeded with 5 ml of
exponentially growing strains of S. aureus, and used to overlay
TSA plates. Sterile filter disks were placed in the centre of the
overlayed plates, and 10 ml of the test chemicals was applied at the
following concentrations: 30% H202, 80% cumene hydroperoxide,
500mM diamide, 2M methyl viologen, 1% menadione, 100mM
plumbagin, 400 mg ml21 pyrogallol, 100mM sodium nitroprus-
side, 10% SDS, 10% Triton X-100, 12M HCl, 6M NaOH, 95%
ethanol, 2 mg ml21 bacitracin, 2 mg ml21 vancomycin, 5 mg
ml21 penicillin G and 20 mg ml21 puromycin. This technique was
also adapted for transcription profiling using the SH1000 sigS-lacZ
strain. In this situation 5 ml of exponentially growing sigS-lacZ cells
was seeded into 5 ml of TSB top agar (0.7%, wt/vol) containing
X-GAL (40 mg ml21). This was then used to overlay TSA plates
before sterile filter discs (3 per plate) were placed on top of the agar
overlay. Filter discs were then seeded with 10 ml of the same stress
inducing chemicals listed above.
Cell Wall Lysis Experiments
Lysis kinetics using lysostaphin and Triton X-100 were
performed as described previously [81]. Penicillin G lysis was
performed as described by Fujimoto & Bayles [82].
Coculture experiments
SH1000 and the SH1000 sigS mutant were grown in
competitive culture experiments as described previously by
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Doherty et al [83]. Briefly, both strains were grown separately for
18h in TSB under standard conditions. Cells were harvested by
centrifugation, washed with PBS and used to inoculate fresh TSB
with an inoculation ratio of 1:1. These ratios were confirmed by
retrospective viable counts of the starting inoculum in triplicate.
Cultures were incubated at 37uC for the times specified and viable
counts were again determined in triplicate. These experiments are
facilitated by the tetracycline resistance cassette used to mark the
sigS mutant. Therefore plating dilutions of the coculture on both
TSA, and TSA containing tetracycline, allows derivation of exact
colony counts for each strain, and thus calculation of the
competitive index (CI).
Experimental models of S. aureus sepsis and arthritis
Female NRMI mice, 6 to 8 weeks old, were purchased from B
& K Universal AB (Sollentuna, Sweden) and kept in the animal
facility of the Department of Rheumatology and Inflammation
Research, Go¨teborg University. S. aureus strain SH1000 and its
isogenic sigS mutant were cultured on horse-blood agar plates at
37uC for 24 hours, harvested, washed in PBS and resuspended in
PBS supplemented with 10% dimethyl sulfoxide and 5% bovine
serum albumin. Aliquots of bacterial suspensions with a known
CFU/ml, as determined by viable counts, were stored at 220uC.
Before inoculation, bacterial cultures were thawed, washed once
with PBS and diluted in PBS to the desired concentration. In five
independent experiments mice were inoculated intravenously with
200 ml of bacterial suspension in declining bacterial doses (86106,
66106, 4.56106, 46106, and 36106 CFU/mouse). Viable counts
of the inoculum were performed in each experiment to confirm
the accuracy of each dose. Mice were individually monitored for
up to 14 days by an observer (CL) blinded to the identity of the
experimental groups for general appearance, weight change,
mortality, and the development of arthritis, before being sacrificed.
Clinical arthritis, defined by visible erythema and/or swelling of at
least one joint, was scored from 0 to 3 for each limb (1, mild
swelling and/or erythema; 2, moderate swelling and erythema; 3,
marked swelling and erythema). An arthritic index was generated
by adding the scores for each limb of a given animal.
Histopathological evaluations of the limbs were performed after
routine paraformaldehyde fixation, decalcification, paraffin em-
bedding, and hematoxylin and eosin staining. Tissue sections were
evaluated for synovitis and joint destruction by an observer (CL)
blinded to the identity of the groups. Synovitis and cartilage/bone
destruction were scored separately as 0, none; 1, mild; 2,
moderate; and 3, for severe synovial hypertrophy and joint
damage. The sum of all of the limbs was used to calculate a
histopathology score.
Bacterial persistence in host tissues was evaluated by aseptically
removing the kidneys, homogenizing them and performing viable
counts after serial dilution in PBS. The CFU/ml were determined
after 24 hours of cultivation on horse blood agar plates. Serum IL-
6 concentrations were determined as previously described, using a
bioassay in which the murine hybridoma cell line B9 is dependent
on IL-6 for growth, [84]. All samples were run in triplicate, and
the statistical evaluations of weight change and severity of clinical
and histopathological arthritis between groups was performed
using a Mann-Whitney U test. A chi-square test was used for
comparison of frequency of clinical arthritis between groups, whilst
the comparison of mortality was done by a log rank test. A p-value
,0.05 (after Bonferroni correction for multiple comparisons) was
deemed to indicate statistically significant differences.
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